Osimertinib in central nervous system progressive EGFR-mutant lung cancer: do we need to detect T790M?

S. Park; M. J. Ahn

doi:10.1016/j.annonc.2020.08.2234

Osimertinib in central nervous system progressive EGFR-mutant lung cancer: do we need to detect T790M?

S. Park
, M. J. Ahn

Sungkyunkwan University

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1582
Number of pages	1
Journal	Annals of Oncology
Volume	31
Issue number	11
DOIs	https://doi.org/10.1016/j.annonc.2020.08.2234
State	Published - Nov 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.annonc.2020.08.2234

Cite this

@article{40f5ddc9a2e04cd68f019e8f8ced57c5,

title = "Osimertinib in central nervous system progressive EGFR-mutant lung cancer: do we need to detect T790M?",

author = "S. Park and Ahn, \{M. J.\}",

year = "2020",

month = nov,

doi = "10.1016/j.annonc.2020.08.2234",

language = "English",

volume = "31",

pages = "1582",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "11",

}

TY - JOUR

T1 - Osimertinib in central nervous system progressive EGFR-mutant lung cancer

T2 - do we need to detect T790M?

AU - Park, S.

AU - Ahn, M. J.

PY - 2020/11

Y1 - 2020/11

UR - https://www.scopus.com/pages/publications/85092167404

U2 - 10.1016/j.annonc.2020.08.2234

DO - 10.1016/j.annonc.2020.08.2234

M3 - Letter

C2 - 32890631

AN - SCOPUS:85092167404

SN - 0923-7534

VL - 31

SP - 1582

JO - Annals of Oncology

JF - Annals of Oncology

IS - 11

ER -

Osimertinib in central nervous system progressive EGFR-mutant lung cancer: do we need to detect T790M?

UN SDGs

Access to Document

Other files and links

Cite this